We aimed to evaluate the effect of selected polymorphisms of the ACTN3, ACE, HIF1A and PPARA genes on the immediate supercompensation training effect of elite Slovak endurance runners and football players compared with a sedentary control group. Adaptation effect levels were evaluated by 10 s continuous vertical jump test parameters measured by Optojump. Genetic polymorphisms were determined by PCR and Sanger sequencing. We found significant differences in the effect of PPARA genotypes in the experimental group. C allele genotypes represented an advantage in immediate supercompensation (p < 0.05). We observed a significant combined effect of multiple genes on immediate supercompensation (p < 0.05): the RR genotype of the ACTN3 gene, the ID genotype of the ACE gene, the Pro/Pro genotype of HIF1A, and the GC and GG genotypes of PPARA genes. In the control group, we found a significant effect (p < 0.05) on immediate supercompensation of the II genotype of the ACE gene and the Pro/Ser genotype of the HIF1A gene. We found significant differences in genotype frequency of ACE (p < 0.01) and PPARA (p < 0.001) genes. We confirmed that individual genetic polymorphisms of ACTN3, ACE, HIF1A and PPARA genes have a different effect on the level of immediate supercompensation of the lower limbs depending on the training adaptation of the probands and the combination of genotypes.
Background/objectives: The study aims to investigate potential differences in vertical jump performance between elite basketball and volleyball players before and after a standard training session, in comparison to a control group from the general population. The analysis focuses on the influence of selected gene polymorphisms that may contribute to variations in the assessed performance parameters. Aims: The aim was to investigate the influence of ACE (rs4646994), ACTN3 (rs1815739), PPARA rs4253778, HIF1A (rs11549465), and AMPD1 (rs17602729) genes polymorphisms on the combined effects of post-activation potentiation (PAP), post-activation performance enhancement (PAPE), and general adaptation syndrome (GAS), as reflected in vertical jump performance, in elite basketball and volleyball players compared to a control group from the general population. Methods: The effects of PAP at the beginning of the training load (acute exercise), and the combined influences of PAPE and GAS following the training load were evaluated using parameters measured by the OptoJump Next® system (Microgate, Bolzano, Italy). Results: A statistically significant (h, p < 0.05) negative effect of the CT genotype of the AMPD1 gene on jump height was observed in the group of athletes. The CT genotype of the AMPD1 gene negatively impacted on PAPE and GAS adaptive responses (ΔP, Δh, p < 0.001) also in the control group. A positive effect on the power during the active phase of the vertical jump was identified for the II genotype of the ACE gene and the Pro/Ser genotype of the HIF1A gene, both exclusively in the control group (ΔP, p < 0.05). Conclusion: Our findings demonstrate that different gene polymorphisms exert variable influences on the combined effects of PAPE and GAS, as reflected in vertical jump parameters, depending on the participants’ level of training adaptation.
The aim of this study was to investigate the acute and delayed effects of two postactivation performance enhancement (PAPE) protocols on countermovement jump (CMJ) height without arm work. 16 strength-trained male participants from various team sports performed, in a single-group, non-synchronous crossover experiment, two different PAPE protocols: traditional resistance using free weights (TR) and resistance generated using an isoinertial flywheel device (FW). Familiarization sessions were conducted prior to the protocols. The TR protocol resistance was set at power maximum (Pmax) determined through diagnostic series of progressive loading. The FW protocol used an encoder to set resistances, and the resistance with the highest Pmax in concetric phase was selected. Each protocol consisted of 3 sets of 6 repetitions with a 2-minute rest interval. CMJ height was measured at baseline, 6 minutes, and 24 hours after the both PAPE protocols. The CMJ height significantly increased at 6 minutes after FW protocol (p < 0.01) and after TR protocol (p < 0.05) but did not significantly increase after 24 hours after both protocols (p < 0.05). In conclusion the FW and TR protocol showed significant increases after 6 minutes but not after 24 hours in CMJ height. This suggests that FW and TR protocol can be a effective method for acutely inducing CMJ height improvements but not after 24 hours.
The aim of our study is to substantiate and confirm the importance of the level of running stride parameters and explosive power of the lower limbs of young basketball players in achieving acceleration speed. The research population consisted of U13 (n = 11) and U15 (n = 16) players who have been participating in a regular specialized training program for at least 2 years. Testing was conducted using the Optojump next device in the 15 m acceleration race. The literature refers to the 1st and 2nd running steps as key. In our study, we focused on the evaluation of the first 6 running steps. We performed 3 vertical jump protocols (CMJ (counter movement jump), CMJ- free arms and SQ (squat jump)) to determine the level of explosive power of the lower limbs. We observed a significant relationship between the level of acceleration velocity and CMJ (p < 0.05, r = -0.610), CMJ-free arms (p < 0.05, r = -0.728) in the U13 category. In the U15 category, a significant relationship was found in CMJ (p < 0.01, r = - 0.720), CMJ-free arms (p < 0.01, r = - 0.688) and SQ (p < 0.01, r = - 0.872). In the U13 category, we observed a significant relationship between the level of acceleration speed at 15 m and pad contact time in the 4th (p < 0.01, r = 0.740) running stride. Running stride length was not significant with acceleration speed level in the U13 category. In the U15 category, we observed a significant relationship between the level of acceleration speed at 15 m and the contact time with the mat in the 1st (p < 0.05, r = 0.619), 3rd (p < 0.01, r = 0.709), 5th (p < 0.01, r = 0.783) and 6th (p < 0.05, r = 0.593) running stride. Running stride length in relation to acceleration velocity was not significant in either running stride in the U15 category.